NCT00578708View on ClinicalTrials.gov

Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2010

Study Completion Date

September 30, 2010

Conditions
Membranous Ventricular Septal Defects
Interventions
DEVICE

AMPLATZER Membranous VSD Occluder

Device closure with the AMPLATZER Membranous VSD Occluder

Trial Locations (6)

10032

Columbia University, New York

29425

Medical University of South Carolina, Charleston

43205

Columbus Children's Hospital, Columbus

55455

University of Minnesota, Minneapolis

63110

Washington University Medical Center, St Louis

68114

Children's Hospital UN/CU), Omaha

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00578708 - Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER | Biotech Hunter | Biotech Hunter